We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MLM:NYSEMartin Marietta Materials, Inc. Analysis

Data as of 2026-07-30 - not real-time

$542.11

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Martin Marietta Materials (MLM) is trading around $542, roughly 95% above its DCF‑derived fair value of $278 and 25% above the consensus target median of $700, indicating a substantial pricing premium. Technicals are bearish: the price sits below the 20‑day, 50‑day and 200‑day moving averages, RSI is near 40, and the MACD histogram is negative, with support near $540 and resistance near $607. Volatility is high at over 36% for the past 30 days, though beta is sub‑market at ~0.8, suggesting price swings are driven more by sector‑specific dynamics than market moves.
Fundamentally, the company posted a record Q2 with revenue up 21% YoY to $1.95 bn, strong operating margins (12.7% operating, 39.9% profit) and $350 m of projected cash‑flow benefits from efficiency initiatives. Cash flow remains robust ($1.79 bn operating, $842 m free) and the dividend payout is modest at 20% of earnings, supporting dividend sustainability. However, the current valuation (PE ~34, forward PE ~24, PB ~2.9) appears stretched relative to peers, and the market’s “Extreme Greed” sentiment (FGI 89) adds a contrarian caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages and technical bearish signals
  • Current price far exceeds DCF fair value
  • High short‑term volatility and proximity to support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and operating efficiency gains
  • Robust cash generation supporting dividend and debt service
  • Valuation still elevated but fundamentals remain solid

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑run infrastructure demand underpinning demand for aggregates
  • Sustainable dividend with low payout ratio
  • Potential for valuation correction as market sentiment normalizes

Key Metrics & Analysis

Financial Health

Revenue Growth17.20%
Profit Margin39.91%
P/E Ratio34.0
ROE9.47%
ROA4.78%
Debt/Equity50.35
P/B Ratio2.9
Op. Cash Flow$1.8B
Free Cash Flow$841.8M

Technical Analysis

TrendBearish
RSI40.1
Support$539.96
Resistance$607.19
MA 20$569.80
MA 50$575.05
MA 200$612.11
MACDBearish
VolumeStable
Fear & Greed Index89.36

Valuation

Fair Value$278.34
Target Price$679.78
Upside/Downside25.40%
GradeOvervalued
TypeBlend
Dividend Yield0.58%

Risk Assessment

Beta0.82
Volatility36.44%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.